Cannell & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Cannell & Co’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,045	Closed	-$373K	–	287
2022 Q1	$373K	Hold	9,045	–	–	0.01%	237
2021 Q4	$385K	Hold	9,045	–	–	0.01%	238
2021 Q3	$498K	Sell	9,045 -6,465	-42%	-$338K	0.02%	222
2021 Q2	$742K	Sell	15,510 -58,705	-79%	-$2.99M	0.02%	198
2021 Q1	$3.76M	Hold	74,215	–	–	0.12%	119
2020 Q4	$4.67M	Sell	74,215 -51,000	-41%	-$3.16M	0.16%	107
2020 Q3	$8.42M	Sell	125,215 -122,431	-49%	-$6.68M	0.31%	81
2020 Q2	$10.4M	Hold	247,646	–	–	0.41%	65
2020 Q1	$7.8M	Sell	247,646 -53,000	-18%	-$2.12M	0.37%	72
2019 Q4	$12.1M	Buy	+300,646	New	+$10.5M	0.43%	72

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Cannell & Co's SILK Position: Q2 2022 in Review

Cannell & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2022, closing a stake of 9,045 shares — an estimated $373K sold.

Cannell & Co first reported a position in SILK in Q4 2019 and held it in 10 quarters. The position peaked at $12.1M in Q4 2019. 139 funds tracked by Wall St. Rank hold SILK as of Q2 2022.

Cannell & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Cannell & Co sold 9,045 Silk Road Medical, Inc. Common Stock shares in Q2 2022, an estimated $373K.
Cannell & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
Cannell & Co's Silk Road Medical, Inc. Common Stock position peaked at $12.1M in Q4 2019.
139 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2022.

Based on Cannell & Co's 13F filing for Q2 2022, filed 8 Aug 2022.